Oramed Pharmaceuticals
ORMP
#9161
Rank
NZ$0.15 B
Marketcap
$3.74
Share price
-3.15%
Change (1 day)
-29.78%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): NZ$39.85 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of NZ$12.39 Million, an increase over its 2022 earnings that were of -NZ$63.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$39.85 M221.54%
2023 NZ$12.39 M-119.45%
2022 -NZ$63.73 Million39.17%
2021 -NZ$45.79 Million73.93%
2020 -NZ$26.33 Million18.53%
2019 -NZ$22.22 Million-16.62%
2018 -NZ$26.64 Million38.32%
2017 -NZ$19.26 Million12.51%
2016 -NZ$17.12 Million25.01%
2015 -NZ$13.7 Million18.18%
2014 -NZ$11.59 Million39.72%
2013 -NZ$8.3 Million46.4%
2012 -NZ$5.67 Million128.32%
2011 -NZ$2.49 Million-51.47%
2010 -NZ$5.12 Million35.21%
2009 -NZ$3.79 Million
2007 -NZ$5.95 Million607.04%
2006 -NZ$0.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.87 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.95 B 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
NZ$12.88 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$26.31 M-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-NZ$0.38 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA